Recombinant human factor IX and use thereof

摘要

The present invention aims at converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with triple replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor IX.